As shown in the waterfall plot (Figures 6A, B), tumor mutational burden (TMB) differences exist in two subtypes, and the mutation frequency of TP53, MUC16, and PCLO in the high risk group was significantly higher than those the low risk group. This evidence concerns the gene TP53 and neoplasm.